Cellosaurus RCi002-B (CVCL_9S44)
| Cell line name | RCi002-B |
|---|---|
| Synonyms | RCi93; FP5C-16; EM5-16 |
| Accession | CVCL_9S44 |
| Resource Identification Initiative | To cite this cell line use: RCi002-B (RRID:CVCL_9S44) |
| Comments | From: Pfizer, Inc.; New York; USA. From: Roslin Cells, Ltd; Roslin; United Kingdom. Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. |
| Sequence variations |
|
| Disease | Erythromelalgia (NCIt: C34593) Primary erythromelalgia (ORDO: Orphanet_90026) |
| Species of origin | Homo sapiens (Human) (NCBI Taxonomy: 9606) |
| Originate from same individual | CVCL_9S43 ! RCi002-A |
| Sex of cell | Female |
| Age at sampling | <2Y |
| Category | Induced pluripotent stem cell |
| Publications | PubMed=27099175; DOI=10.1126/scitranslmed.aad7653 |
| Cross-references | |
| Cell line collections (Providers) | EBiSC; RCi002-B
ECACC; 66540050 - Discontinued |
| Cell line databases/resources | hPSCreg; RCi002-B
SKIP; SKIP002475 |
| Biological sample resources | BioSamples; SAMEA3106075 |
| Encyclopedic resources | Wikidata; Q54949501 |
| Entry history | |
| Entry creation | 23-Feb-2016 |
| Last entry update | 19-Dec-2024 |
| Version number | 15 |